Antifungals Flashcards

(46 cards)

1
Q

amphoB MOA

A

binds to ergosterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

spectrum (CACEZ)

A

BROAD

Candida, Aspergillus, cryptococcus, endemics, zygomycetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

amphoB adjust for organ dysfxn?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

amphoB toxicity

A

Nephrotoxicity (TG feedback –> constriction; RTA –> spill electrolytes) loss of H/K/Mg
Anemia
Infusion fever/rigors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

lipid amphoB

A

gentler - reduces SE’s by 20x

but less potent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

indications for amphoB

A

1st line for:
Crypt. Meningitis
Endemics
Initial tx for Zygomycoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tx of zygomycetes?

A

AmB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cryptococcal meningitis 1st line?

A

AmB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Azole MOA

A

block an enzyme in the ergosterol synth pathway
static for candida
cidal for aspergillus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Azole spectrum

A

Candida (not glabrata/krusei)
Cryptococcus
Endemics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

big candida problem in the hospital

A

Glabrata

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Azoles NOT good for

A

Aspergillus

Zygomycetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fluconazole kinetics

A

Gets where we want it to get
renal elimination
drug interactions: CYP450 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fluconazole toxicity

A

teratogenicity limits in pregnancy

QT prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fluconazole indications

A

1st line: mucosal candidiasis
1st line: step-down for invasive candidiasis and cryptococcal meningitis
1st line for candida cystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mucosal candidiasis tx

A

fluconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Itraconazole spectrum

A

More potent against endemic fungi
Candida/Crypto/aspergillus/dermatophytes
Not zygomycetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Itraconazole kinetics

A
VARIABLE absorption (not sure how much pt will actually get)
depends on acid/food status of stomach
poor CNS/urine distribution
no change for renal dysfunction
BIG TIME CYP450 inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Itraconazole toxicity

A

more GI than fluconazole
QT prolong
same teratogenicity problem

20
Q

Itraconazole indications

A

1st line for dermatophytes

1st line step down for endemics

21
Q

Voriconazole spectrum

A

closer to itra than flu
Aspergillus terreus (not gotten by amphora)
endemics/crypto
not zygomycetes

22
Q

Voriconazole kinetics

A
Does not get in urine
Yes CNS
No need for food or acid
SHORT half-life
**liver metabolism: CYP2C19 (thus need TDM)
CYP450 inhibitor
23
Q

voriconazole toxicity

A

most toxic among triazoles
VISUAL photopsia, photosensitivity –> sunburns
more hepatotoxicity

24
Q

Voriconazole indications

A

1st line: BEST for invasive aspergillosis, fusarium, scedosporium
endemics/cryptococcal meningitis

25
Posaconazole
ZYGOMYCETES + the rest
26
Posaconazole kinetics
need lipids acid needed, better w/food poor CNS, no urine TDM
27
Posaconazole toxicity
OK | ...but less information than other triazoles
28
Posaconazole indications
1st line prophylaxis in HEME malignancy/BMT 1st line ZYGOMYCETES (only other option is AmphoB) 2nd line for other infections (endemics e.g.)
29
Isavuconazole
Same is posaconazole
30
Isavuconazole advantages
``` kinetics: well-absorbed, IV formulation no need for acid or food no need for TDM no change for renal/hepatic dysfunction few drug interactions CYP3A4 ```
31
Isavuconazole SE's
minimal
32
Isavuconazole indications
1st line for aspergillus/zygomycestes, fusarium, scedosporum | 2nd line for candidiasis and endemics
33
flucytosine
inhibits DNA/protein synthesis candida (all) and crypto Nothing else
34
Flucytosine kinetics
oral only CNS and urine excellent no drug interactions change dose for renal dysfxn
35
Flucytosine toxicity
``` life-threatening toxicity with amphoB --> nephrotoxicity Bone marrow suppression Hepatitis *due to accumulation of 5-FC in blood So use TDM ```
36
Flucytosine primary use
cryptococcal meningitis (w/AmphoB) candida cystitis
37
Echinocandin MOA
inhibit B-D-glucan synthase
38
Echinocandin kinetics
IV only Poor CNS/eye/urine minimal toxicity
39
Echinocandin spectrum
CIDAL for all candida (except parapsilosis) Static for Aspergillosis NO cryptococcus/endemics/zygo/dermatophytes
40
Echinocandin indications
1st line for invasive candidiasis (not CNS/eye) Combo w/voriconazole for aspergillosis Prophylaxis for heme malig/BMT
41
Candidiasis
mucosal: topical azoles, oral flucon systemic: AmB, flucon
42
Aspergillosis
Voriconazole AmB Itraconazole (for mild)
43
Cryptococcosis
GOLD STD: AmB + 5-FC | Flucon for mild & suppression
44
Histoplasmosis/Blastomycosis
AmB for severe Itracon for non-life threatening/non-CNS Voricon/Posacon
45
Coccidioidomycosis
AmB for severe Flucon/itracon less effective Flucon for meningitis due to kinetics Voricon/Posacon
46
Dermatophytes
Terbinafine >> Itracon | Terb: fewer SE's and no interactions